Title |
Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma
|
---|---|
Published in |
Cancer Management and Research, August 2012
|
DOI | 10.2147/cmar.s35342 |
Pubmed ID | |
Authors |
Francesco Di Pierro Francesco, Alberto Bonetta |
Abstract |
Cranberry (Vaccinium macrocarpon) proanthocyanidins can interfere with adhesion of bacteria to uroepithelial cells, potentially preventing lower urinary tract infections (LUTIs). Because LUTIs are a common side effect of external beam radiotherapy (EBRT) for prostate cancer, we evaluated the clinical efficacy of enteric-coated tablets containing highly standardized V. msacrocarpon (ecVM) in this condition. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 17% |
United States | 1 | 17% |
Unknown | 4 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Scientists | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 67 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 17 | 25% |
Researcher | 8 | 12% |
Student > Postgraduate | 7 | 10% |
Student > Ph. D. Student | 6 | 9% |
Student > Master | 5 | 7% |
Other | 15 | 22% |
Unknown | 9 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 42% |
Agricultural and Biological Sciences | 13 | 19% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 10% |
Nursing and Health Professions | 4 | 6% |
Veterinary Science and Veterinary Medicine | 1 | 1% |
Other | 2 | 3% |
Unknown | 12 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2017.
All research outputs
#2,544,900
of 24,837,507 outputs
Outputs from Cancer Management and Research
#62
of 2,053 outputs
Outputs of similar age
#15,893
of 169,483 outputs
Outputs of similar age from Cancer Management and Research
#1
of 15 outputs
Altmetric has tracked 24,837,507 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,053 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,483 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.